NDRA vs NWS · P/E 0.0, $2.6M cap vs rev $9.03B
ENDRA Life Sciences Inc (NDRA) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
NWS (NWS) common stock.
NDRA does not have a complete income-statement cache yet.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. NWS currently screens at market cap $0.
Not investment advice. Open the NDRA and NWS stock pages for the full models.
Not investment advice.